It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
N6-methyladenosine (m6A) is a dynamic post-transcriptional RNA modification influencing all aspects of mRNA biology. While m6A modifications during numerous viral infections have been described, the role of m6A in innate immune response remains unclear. Here, we examined cellular m6A epitranscriptomes during infections of Pseudomonas aeruginosa and herpes simplex virus type 1 (HSV-1), and lipopolysaccharide (LPS) stimulation to identify m6A-regulated innate immune response genes. We showed that a significant portion of cellular genes including many innate immune response genes underwent m6A modifications in 5'UTR and 3'UTR. We identified common and distinct m6A-modified genes under different stimulating conditions. Significantly, the expression of a subset of innate immune response genes was positively correlated with m6A level. Importantly, we identified genes that had significant enrichments of m6A peaks during P. aeruginosa infection following knockdown of m6A “eraser” ALKBH5, confirming the regulation of these genes by m6A and ALKBH5. Among them, we confirmed the association of m6A modification with gene expression in immune response genes TNFAIP3, IFIT1, IFIT2 and IFIH1. Taken together, our results revealed the vital role of m6A in regulating innate immunity against bacterial and viral infections. These works also provided rich resources for the scientific community.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Pittsburgh, Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Microbiology and Molecular Genetics, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
2 University of Texas Health Science Center at San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
3 University of Southern California, Department of Molecular Microbiology and Immunology, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
4 University of Texas Health Science Center at San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); University of Texas Health San Antonio, Department of Molecular Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
5 University of Texas Health Science Center at San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); University of Texas Health San Antonio, Department of Populational Health Science, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
6 University of Pittsburgh, Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
7 University of Pittsburgh, Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Microbiology and Molecular Genetics, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Southern California, Department of Molecular Microbiology and Immunology, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)